For 50 years, CRA has been a premier consulting firm. Each of our practice areas is highly regarded, and our consultants are recognized for their creative and multi-disciplinary approach to solving our clients’ complex problems in the US and throughout the world.

The rise of drug prices: What will US payers do next?

Lev Gerlovin
Life Sciences

Lev Gerlovin explores the future of payer response to rising drug prices and discuss strategies that manufacturers may consider to gain a competitive edge in this evolving landscape.

Download PDF